Jason Wu

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

C. William Hanke, Kenneth Beer, Eggert Stockfleth et al. · Journal of the American Academy of Dermatology · 2010 · 156 citations

Imiquimod 2.5, Ophthalmology, 3-Week Cycles +7

Psoriasis induced by topical imiquimod

Jason Wu, Greg Siller, Geoff Strutton · Australasian Journal of Dermatology · 2004 · 145 citations

Imiquimod 3.75% Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies

David A. Baker, Daron G. Ferris, Mark G. Martens et al. · Infectious Diseases in Obstetrics and Gynecology · 2011 · 50 citations · Full text

An open‐label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

Jason Wu, Carol Oh, Geoff Strutton et al. · Australasian Journal of Dermatology · 2006 · 43 citations

Tele-assessment of Psoriasis Area and Severity Index: A study of the accuracy of digital image capture

Philip Singh, H. Peter Soyer, Jason Wu et al. · Australasian Journal of Dermatology · 2011 · 32 citations